+ Conflict of Interest in Physician-Industry Relationships.

Slides:



Advertisements
Similar presentations
1 Conflicts of interest Different types, different contexts.
Advertisements

Professional Education Support Wyeth Pharmaceuticals Melinda Somasekhar, PhD.
Physician Relationships with The Pharmaceutical Industry Steven R. Craig, MD, FACP June 22, 2010.
Pharmacy Benefit Managers (PBMs)
Continuing Professional Development Conflict of Interest This presentation has been developed by the COI Working Group to assist in the implementation.
Integrity and impartiality
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
Promoting Integrity in the Next Generation of Researchers A Curriculum for Responsible Conduct of Research in Occupational Therapy (2005) Funded by the.
Competing interests Jaideep A Gogtay MD Conflict of Interest Employee of Cipla Ltd.
Conflict of Interest in Physician-Industry Relationships
Conflict of Interest: Dartmouth College. Why do we care about it ? Conflict of Interest in Research : Unbiased research: design, conduct, reporting Maintain.
National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships Rev. 10/21/2014 APGO Interaction with Industry: A Medical.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
Pharmaceutical Compliance Congress: “State of the States” October 27, 2008 Janice G. Cunningham Jeffrey L. Handwerker.
Medicare Parts C and D Fraud, Waste, and Abuse Compliance Training
1 UCDHS Vendor Relations Policy Development & Implementation Teresa Porter, CHC - Chief Compliance Officer David Levine, JD - Legal Counsel Allan Siefkin,
Advertising of rx medicinal products to the general public The case MSD Sharpe & Dohme GmbH vs. Merckle GmbH (C-316/09) Judgment of the ECJ of 5 May 2011.
Conflict of Interest. Definition  “A conflict of interest is a situation in which financial or other personal considerations have the potential to compromise.
Ethical Issues.
International Experience in Pharmaceutical Services for Promoting Access to Medicines: Canada, Cuba, England, Mexico International Seminar on the Challenges.
Conflict of Interest Faculty & Staff of Instruction or Research Human Resources 2011.
Clarity, consent and coverage for research-related injuries 6 th Annual Columbia University IRB Conference Boston, MA Patrick Taylor Children’s Hospital.
Fall 2014 Kate Walker, Vice President for Finance and Treasurer
Towards an Integrity Standard in the Pharmaceutical Industry IACC Conference, May 27, 2003 Seoul, Korea Dr. Jillian Clare Cohen Assistant Professor, Leslie.
A REVIEW FOR ALL PRESENTERS OF ASMBS-SPONSORED EDUCATIONAL ACTIVITIES ASMBS CME Policies, Procedures and Guidelines for Presenters.
External Influences on Prescribing Practice Karen Ford.
CHCWG DRAFT March 2, 2006 Hearing from the American People: Preliminary Overview of Sources and Reports March 2006 Caution: Preliminary Data Do not cite.
# Operating Under the New Compliance Environment: Considerations for the Pharmaceutical Industry The Impact of the new Medicare Prescription Drug benefit.
THE ORTHOPAEDIC SURGEON’S RELATIONSHIPS WITH INDUSTRY AAOS ETHICS COMMITTEE Kenneth C. Thomas, MD 1.
Open Payments Act AKA the ‘Sunshine Act’ Open Payments Act AKA the ‘Sunshine Act’ Public Postings of Physician Ownership, Investments, & Transfers of Value.
Role of Industry in Clinical Care, Research and Education Rev 10/21/2014 APGO Interaction with Industry: A Medical Student Guide.
VCU School of Medicine Policy on Industry Relations Effective July 1, 2009.
The Ohio Ethics Law Carrie Williams. Purpose  Provide an overview of The Ohio Ethics Commission and The Ohio Ethics Law  Explain the components of The.
Voluntary Codes MassMEDIC Meeting Are You Ready to Comply with Massachusetts’ New Pharmaceutical and Medical Device Code of Conduct Law? Linda D. Bentley,
New Staff Orientation: Industry Relations Emory School of Medicine Zainab R. Wurie, JD July 15, 2014.
Impact Health NDAC Meeting Stewart Levy R.Ph. January 14, 2005.
Todd Hamilton District Sales Manager. Innovation  On average it takes scientists, physicians, engineers, and other researchers between 10 and 15 years.
 Tracy L. LeGrow, Psy.D. Associate Professor Department of Psychiatry and Behavioral Medicine.
“Delivering Therapeutic Agents” - Marketing and Communication Strategies of Drug Companies Safura Nantogmah.
Security of the Distributed Electronic Patient Record: A Case-Based Approach James G. Anderson, Ph.D. Purdue University.
Research Conflicts of Interest: Identifying and Minimizing COI from the Perspective of Faculty July 30, 2009 PonJola Coney, MD Senior Associate Dean for.
Vendor Relations Policy. Why Is There A Policy? The Patient Protection and Affordable Care Act was signed into law March 23, The new law contains.
+ National and Institutional Guidelines on Conflict of Interest in Physician-Industry Relationships.
A Focus on CME and Grants Nancy Coddington, PhD Senior Director, Compliance Operations AstraZeneca Pharmaceuticals LP And Terry Hisey Deputy Managing Principal.
KEY ENFORCEMENT ISSUES - The Government's Perspective Kathleen Meriwether Assistant United States Attorney Eastern District of Pennsylvania UNITED STATES.
Disclosure of Financial Conflicts of Interest in Continuing Medical Education Michael D. Jibson, MD, PhD and Jennifer Seibert, MD University of Michigan.
UC DAVIS OFFICE OF RESEARCH Overview of Good Clinical Practices (GCP) Investigator and Study Team Responsibilities Miles McFann IRB Administration Training.
+ Role of Industry in Clinical Care, Research, and Education.
 the study of the rightness or wrongness of human conduct.  In any situation involving two or more individuals, values may come into conflict and ethical.
Partners Conflict of Interest Policy and Reporting October 11, 2012.
The Physician - Pharma Relationship.  Is very old and very close  But are the goals of pharmaceutical companies and medicine the same?
Sara Lovell, CPCS Education Coordinator Providence Alaska Medical Center.
Stanford Policy – Faculty ◦ Mission: Promote public good by transferring knowledge  Consulting  Technologies arising from research These activities can.
$100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 Terms Clinical Trial Facts.
Shelly Rose Ziegler. Overview Gifts from Industry Industry Site Access Academic Activities Questions  Growing external perception that industry has influence.
Ethics Case 1 Remonte. Rivera, K., Sagayaga. Siy. Talan.
Compliance Issues in Dealing With Drug and Device Manufacturers Presentation to The Sixth Annual National Congress On Health Care Compliance Paul E. Kalb,
0 Delegation of Services & Co-management The Co-management Dilemma.
H ⊕ lger Schünemann, MD, PhD Professor and Chair, Dept. of Clinical Epidemiology & Biostatistics Professor of Medicine Michael Gent Chair in Healthcare.
Objective 1.03 Understanding Ethics Needed For Employment In Accounting 1 Objective 1.03 Understanding Ethics.
“Conflicts of Interest”
44 Nursing: A Concept-Based Approach to Learning Ethics MODULE
Unnecessary Procedures- Billing
Accounting I Objective 1.03 Understanding Ethics Needed
Communication Skills Lecture 1-2
Common Ethical Considerations in Pharmaceutical Care Practice
1.03 Understanding Ethics ACCOUNTING I
AGREEMENT FOR TRANSPARENCY The Case of Mexico
Brussels, June 6, 2007 Paul E. Kalb, M.D., J.D.
Updates to the PhRMA Code on Interactions with Healthcare Professionals National Pharma Audioconference August 5, 2008.
Presentation transcript:

+ Conflict of Interest in Physician-Industry Relationships

+ Objectives Define conflict of Interest Recognize situations where conflict of interest may occur in the physician-industry relationships Cite strategies on managing potential conflict of interest

+ Conflict of Interest Definition American Heritage Dictionary: “A conflict between a person's private interests and public obligations.” A potential conflict of interest occurs when there is a possibility that an individual’s private interests, or his or her family’s interests, may influence the individual’s professional actions, decisions, or judgment

+ Physician Conflict of Interest Physician (individual) conflict of interest may arise when there is conflict between the interest of physician and those of the patient (or patients) There exists evidence in the literature which shows that interactions between medical professionals and industry may lead to compromise of professional values and negatively effect the physician-patient relationship

+ Example 1: “Qui tam” The Lupron Case (1997) Relationships between TAP pharmaceuticals and various urologists were questioned regarding use of Lupron in the treatment of prostate cancer TAP encouraged urologists to bill Medicare at the average wholesale price which they received discounted or free TAP also employed doctors as “consultants”, took them on free trips to attend seminars, and awarded unrestricted educational grants

+ Example 1: The Lupron Case (1997) The physicians did not bill TAP for their time, nor did they prepare any reports Federal prosecutors charged TAP with criminal violations of the Prescription Drug Marketing Act TAP settled with the government and paid $290 million in criminal fines plus $585 million in civil penalties The whistle-blowers received nearly $100 million of the total damages

+ Example 2: Dennis Selkoe (1998) A Harvard scientist at Massachusetts General Hospital NIH report endorsing blood test for Alzheimer’s Selkoe signed the report but did note that He helped found Athena Test was manufactured by Athena When Athena went public in 1993, Selkoe had shares worth $3 million

+ Physician-Industry Relationship Physicians goals are to provide good patient care Pharmaceutical companies’ goals are to maximize product sales Physicians are main conduit for sales, which have made them an ideal target for marketing strategies Industry may disseminate certain information that may not necessarily correspond with information the providers need

+ Physician-Industry Relationship Growth in promotional activities has also been accompanied by a rise in industry’s funding of research and education 60% of biomedical research and development is privately funded 70% of clinical trials funding is funded by pharmaceutical companies Industry holds more than half of the costs of formal programs in CME

+ Physician-Industry Relationship Industry spends about $12 billion annually on gifts and payments to physicians Examples of industry practices which can create conflict of interest: Food Gifts (pens, books) Drug samples Support of medical education activities Speakers bureaus and consulting fees Research grants Contact with trainees come early and adheres as physicians move to practice

+ Reality check Prescribing practices of physicians are commonly influenced by subtle and obvious marketing messages and gifts Physicians do not recognize or admit to any changes in their practice of medicine due to these influences In a study of medical residents, 61% were confident that drug companies did not influence their practice, while 16% were equally confident that their colleagues were not influenced by those practices

+ Students Interactions with Industry Medical student-industry interactions are common Students are relatively permissive regarding the acceptance of gifts Students underestimate the influence of these gifts on their behavior It is important as a student to understand physician- industry relationships and the potential risk for conflict of interest

+ Reality check- Medical Students In a study of medical students in the US: 93% were asked to attend at least one sponsored lunch 69% believed gifts would not influence their practice 80% believed they were entitled to gifts 86% of the students who thoughts gifts at a certain amount were inappropriate had accepted one

+ “To maintain integrity and independent-decision making, physicians must ensure that they maintain an impartial relationship with industry representatives free of any influences”

+ Managing Conflict of Interest Strategy for managing conflict of interest : 1. Recognition 2. Disclosure 3. Management

+ Recognition Physicians need to recognize that gifts, regardless of the size do influence behavior and a self-serving bias distorts the way individuals perceive themselves Conflict of interest policies should help individuals recognize potential conflict of interest situations Physicians need to be aware of laws, ethical guidelines, and institutional policies and follow them.

+ Disclosure Disclosure: Financial relationships with industry Research funding and sponsored studies BUT Good intentions are not sufficient given the problem of perception vs. reality, therefore when a conflict of interest is reported, it needs to be carefully reviewed by the appropriate individuals or committee

+ Disclosure Interpretation Studies show that the disclosure of a competing interest in an article affects readers’ perceptions of its interest, importance, validity, relevance and believability Assessment of the quality of the article provides important information (CONSORT statement)

+ Management Elimination of practices that have little or no added clinical value e.g. gifts, free lunches Management of reported conflict of interest to minimize or eliminate the conflict: Public disclosure Independent review Modifying research plan Disqualifying participation

+ Management Elimination of practices that have little or no added clinical value e.g. gifts, free lunches Management of reported conflict of interest to minimize or eliminate the conflict: Public disclosure Independent review Modifying research plan Disqualifying participation

+ Summary Physicians should be aware that conflict of interest exists in their relationships with industry Physicians should learn to eliminate or reduce these conflicts in the interest of their patients

+ Resources National Institutes of Health American Association of Medical Colleges Association of American Universities Council on Government Relations, Financial Conflicts of Interest